Schenker H, Wild M, Rath B, Tingart M, Driessen A, Quack V, Betsch M
Klinik für Orthopädie, Uniklinik RWTH Aachen, Pauwelsstraße 30, 52074, Aachen, Deutschland.
Klinik für Orthopädie, Unfall- und Handchirurgie, Klinikum Darmstadt, Grafenstraße 9, 64283, Darmstadt, Deutschland.
Orthopade. 2017 Nov;46(11):907-913. doi: 10.1007/s00132-017-3474-7.
Cartilage is an avascular, alymphatic and non-innervated tissue with limited intrinsic repair potential. The high prevalence of cartilage defects and their tremendous clinical importance are a challenge for all treating physicians.
This article provides the reader with an overview about current cartilage treatment options and their clinical outcome.
Microfracture is still considered the gold standard in the treatment of small cartilage lesions. Small osteochondral defects can be effectively treated with the autologous osteochondral transplantation system. Larger cartilage defects are successfully treated by autologous membrane-induced chondrogenesis (AMIC) or by membrane-assisted autologous chondrocyte implantation (MACI).
Despite limitations of current cartilage repair strategies, such procedures can result in short- and mid-term clinical improvement of the patients. Further developments and clinical studies are necessary to improve the long-term outcome following cartilage repair.
软骨是一种无血管、无淋巴管且无神经支配的组织,其内在修复潜力有限。软骨缺损的高发生率及其巨大的临床重要性对所有治疗医生来说都是一项挑战。
本文为读者提供当前软骨治疗选择及其临床结果的概述。
微骨折术仍被认为是治疗小面积软骨损伤的金标准。小面积骨软骨缺损可通过自体骨软骨移植系统有效治疗。较大面积的软骨缺损可通过自体膜诱导软骨形成(AMIC)或膜辅助自体软骨细胞植入(MACI)成功治疗。
尽管当前软骨修复策略存在局限性,但这些手术可使患者在短期和中期获得临床改善。有必要进一步开展研究和临床研究以改善软骨修复后的长期效果。